86 ALLOGENEIC TRANSPLANTATION FOR CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) IS ASSOCIATED WITH HIGH DISEASE-FREE SURVIVAL EVEN IN THE SETTING OF HIGH-RISK DISEASE. Issue 1 (April 2015) - Sanchez, M.; Abbi, K.; Tamari, R.; Jakubowski, A.; Papadopoulos, E.; Devlin, S.; Sauter, C.; Barker, J.N.; Boulad, F.; Giralt, S.; Meagher, R.; Castro-Malaspina, H.